“Is the Juice Worth the Squeeze?”: Treatment Intensification for Advanced EGFRm NSCLC
About this episode
The episode discusses the importance of understanding a patient's personality and goals in selecting treatment regimens for advanced EGFRm NSCLC.
With multiple regimens available for advanced EGFRm NSCLC, selecting the best regimen for an individual patient is key. Jorge Nieva, MD, tells host Aakash Desai, MD, MPH, that the questionshouldn’t be about who needs more efficacy, but rather understanding a patient’s personality and goals.
People in this episode
Host: Aakash Desai, MD, MPH
Guest: Jorge Nieva, MD
Topics covered
- EGFRm NSCLC
- treatment intensification
- patient goals
- oncology
- personalized medicine
Keywords
- EGFRm NSCLC
- treatment regimens
- oncology
- patient personality
- treatment goals
Mentioned in this episode
Organizations: Oncology News Central
More episodes of Oncology News Central Peer-Spectives
- New Targeted Therapies Make Breast Cancer Treatment Decisions “a Bit of a Moving Target”
- Advances in ESR1-Mutated Breast Cancer Care Lead to “Complex Situation” in Clinic
- Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care
- Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
- “Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Treatment Decisions
- As Terminal Patients Live Longer, How Can Oncologists Help Them Cope With Uncertainty?
Explore listener stats, chart rankings, contacts and more on the Oncology News Central Peer-Spectives podcast page.